IGC Pharma, Inc. (IGC)

CIK 1326205 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for IGC Pharma, Inc..

Recent SEC filings

FiledFormAccession number
Nov 6, 202610-Q0001185185-26-005237
Oct 22, 2026DEF 14A0001185185-26-004896
Oct 22, 2026DEFA14A0001185185-26-004921
Sep 29, 202640001185185-26-004408
Sep 29, 202640001185185-26-004409
Aug 14, 202610-Q0001185185-26-003544
Jul 14, 20268-K0001185185-26-002922
Jul 6, 20268-K0001185185-26-002808
Jul 1, 202640001185185-26-002765
Jul 1, 202640001185185-26-002764
Jun 8, 20268-K0001185185-26-002410
May 15, 202610-Q0001185185-26-001885
Apr 20, 20268-K0001185185-26-001437
Apr 6, 202640001185185-26-001284
Apr 6, 202640001185185-26-001285
Apr 6, 202640001185185-26-001283
Apr 6, 202640001185185-26-001286
Mar 30, 20268-K0001185185-26-001146
Mar 18, 202610-KT0001185185-26-000941
Mar 12, 20268-K0001185185-26-000846
Feb 4, 202640001185185-26-000411
Jan 20, 202640001185185-26-000218
Jan 6, 2026424B50001185185-26-000030
Jan 6, 20268-K0001185185-26-000032
Jan 2, 20268-K0001185185-26-000010